Our Company
About Us
Leadership
Founders
Board of Directors
Our Approach
Tuning Immune Cell Fate and Function
Targeting Metabolic Pathways to Tune Immune Cells
Product Engine
Our Therapeutic Focus
Therapeutic Focus
Unmet Needs in Immune‑mediated Diseases
Our Workplace
Our Team
Careers
News
Press Releases
Contact
Contact Us
A NEW SETPOINT
for immunometabolism
Tuning immune cells
to bring precision treatments to
immune-mediated diseases.
A NEW SETPOINT
for immunometabolism
Tuning immune cells
to bring precision treatments to
immune-mediated diseases.
The discoveries
of our scientific founders have opened the field of immunometabolism for drug discovery.
Our drug discovery and biomarker approach are driven by our metabolism-centric Immune Cell Encyclopedia (ICE).
March 22, 2018
Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism to Develop Precision Medicines for Immune-mediated Diseases
